Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETTER-B mirtazapine for refractory breathlessness
2019-002001-21Phase 4Unknown
- Sponsor
- King's College London
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Chronic breathlessness syndrome comparing Mirtazapine with Placebo (2 arms). Primary endpoint: Worst breathlessness over the last 24 hours at day 56. Status: unknown.
02
Drugs
mirtazapine
03
Conditions
Chronic breathlessness syndrome
Beyond the preview
Go deeper on 2019-002001-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002001-21.